BRIEF published on 04/08/2025 at 22:10, 1 year 5 months ago Gladstone Capital Declares 2025 Monthly Cash Distributions and Announces Earnings Call Conference Call Earnings Report Cash Distributions Dividend Reinvestment Plan Gladstone Capital
BRIEF published on 04/08/2025 at 22:10, 1 year 5 months ago Gladstone Capital annonce ses distributions mensuelles de trésorerie pour 2025 et sa conférence téléphonique sur les résultats financiers. Conférence Téléphonique Plan De Réinvestissement Des Dividendes Gladstone Capital Distributions En Espèces Rapport Sur Les Bénéfices
BRIEF published on 04/08/2025 at 20:10, 1 year 5 months ago Mise à disposition du rapport financier annuel 2024 d'HDF Energy Rapport Financier Piles À Combustible Hydrogène Infrastructures HDF Energy
BRIEF published on 04/08/2025 at 20:10, 1 year 5 months ago HDF Energy's 2024 annual financial report now available Financial Report Infrastructure Fuel Cells Hydrogen HDF Energy
BRIEF published on 04/08/2025 at 19:29, 1 year 5 months ago Thales Publishes 2024 Universal Registration Document Thales Corporate Governance Universal Registration Document AMF Filing 2024 Financial Report
BRIEF published on 04/08/2025 at 19:29, 1 year 5 months ago Thales publie son Document d’Enregistrement Universel 2024 Thales Rapport Financier Investisseurs Durabilité Document D’enregistrement
BRIEF published on 04/08/2025 at 19:20, 1 year 5 months ago Ondine Biomedical's Steriwave Enters Swiss Medical Trial Antimicrobial Resistance Nasal Decolonization Steriwave Ondine Biomedical Surgical Infections
BRIEF published on 04/08/2025 at 19:20, 1 year 5 months ago Steriwave d'Ondine Biomedical entre dans un essai médical suisse Steriwave Ondine Biomedical Résistance Aux Antimicrobiens Infections Chirurgicales Décolonisation Nasale
BRIEF published on 04/08/2025 at 19:15, 1 year 5 months ago Sanofi : Publication Positive des Données du Tolebrutinib dans le NEJM Sclérose En Plaques Sanofi Phase III NEJM Tolebrutinib
BRIEF published on 04/08/2025 at 19:15, 1 year 5 months ago Sanofi: Positive Publication of Tolebrutinib Data in NEJM Multiple Sclerosis Sanofi Phase III NEJM Tolebrutinib
Published on 09/12/2026 at 02:35, 17 hours 27 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 21 hours 2 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 21 hours 57 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 22 hours 37 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 3 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 2 hours 11 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 12 hours 31 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 21 hours 47 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 21 hours 51 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 13 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 13 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
